CA2205070A1 - Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques - Google Patents

Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques

Info

Publication number
CA2205070A1
CA2205070A1 CA 2205070 CA2205070A CA2205070A1 CA 2205070 A1 CA2205070 A1 CA 2205070A1 CA 2205070 CA2205070 CA 2205070 CA 2205070 A CA2205070 A CA 2205070A CA 2205070 A1 CA2205070 A1 CA 2205070A1
Authority
CA
Canada
Prior art keywords
cells
iymphocytes
oil
hiv
immune system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2205070
Other languages
English (en)
Inventor
Mohamed Benamar
Richard Morisset
Parviz Ghadirian
Fernando St-Hilaire (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ST HILAIRE FERNANDO
Original Assignee
ST HILAIRE FERNANDO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST HILAIRE FERNANDO filed Critical ST HILAIRE FERNANDO
Priority to CA 2205070 priority Critical patent/CA2205070A1/fr
Priority to AU73283/98A priority patent/AU7328398A/en
Priority to PCT/CA1998/000445 priority patent/WO1998051319A1/fr
Publication of CA2205070A1 publication Critical patent/CA2205070A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2205070 1997-05-09 1997-05-09 Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques Abandoned CA2205070A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2205070 CA2205070A1 (fr) 1997-05-09 1997-05-09 Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques
AU73283/98A AU7328398A (en) 1997-05-09 1998-05-06 Antiviral compositions for the stimulation of the immune system and for othe r therapeutic and prophylactic applications
PCT/CA1998/000445 WO1998051319A1 (fr) 1997-05-09 1998-05-06 Compositions antivirales de stimulation du systeme immunitaire etdestinees a d'autres applications therapeutiques et prophylactiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2205070 CA2205070A1 (fr) 1997-05-09 1997-05-09 Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques

Publications (1)

Publication Number Publication Date
CA2205070A1 true CA2205070A1 (fr) 1998-11-09

Family

ID=4160625

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2205070 Abandoned CA2205070A1 (fr) 1997-05-09 1997-05-09 Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques

Country Status (3)

Country Link
AU (1) AU7328398A (fr)
CA (1) CA2205070A1 (fr)
WO (1) WO1998051319A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300624B2 (en) 2004-10-19 2007-11-27 Bruce Kelly Krimpton Crosby Method of disinfecting a building air supply

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526996A (fr) * 1967-02-14 1968-05-31 Produit de beauté
DE2337617A1 (de) * 1973-07-24 1975-02-06 Rudolf Rohrmann Pharmazeutisches praeparat
CA2033737A1 (fr) * 1991-01-07 1992-07-08 Guy Poirier Medicament contre le sida et d'autres infections virales
DE4301266C2 (de) * 1993-01-19 1996-02-01 Wolfgang Metzger Neue Parfümkomplex-Zusammensetzung mit verbesserter Substantivität sowie deren Verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300624B2 (en) 2004-10-19 2007-11-27 Bruce Kelly Krimpton Crosby Method of disinfecting a building air supply

Also Published As

Publication number Publication date
WO1998051319A1 (fr) 1998-11-19
AU7328398A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
Ghoneum Anti-HIV activityin vitroof MGN-3, an activated arabinoxylane from rice bran
JP2656938B2 (ja) ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
CA1326450C (fr) Modulation des manifestations associees au virus du sida au moyen d'arn a double brin
Kobayashi et al. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum
Sidwell et al. In vitro and in vivo Phlebovirus inhibition by ribavirin
US20110086052A1 (en) Activation of innate and adaptive immune responses by a ginseng extract
Fandeur et al. In vitro and in vivo assessement of the antimalarial activity of sergeolide
US7364760B2 (en) Compositions for the treatment of acquired immunodeficiency disease
EP2116253A1 (fr) Nouvel extrait de Phyllanthus
CN102000101A (zh) 野黄芩苷治疗小胶质细胞介导的疾病的用途
US20070134711A1 (en) Compositions of eleutherosides capable of modulating protein expresion
DE3881864T2 (de) Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
CA2205070A1 (fr) Methode et composition permettant d'obtenir un effet antiviral et une stimulation du systeme immunitaire et autres applications therapeutiques et prophylactiques
Khyatti et al. The effect of indometacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells
EP2595627B1 (fr) Utilisation de l'uléine pour la prévention et/ou le traitement du sida
EP1709995A1 (fr) Traitement de l'asthme et de l'allergie utilisant nigella sativa
JPS63309200A (ja) Ｈｉｖの測定方法
Zeidner et al. Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2′, 3′-dideoxycytidine
EP1062947A1 (fr) Remedes contre le sida
WO2018228431A1 (fr) Applications de triterpène saponines extraites de la racine de cimicifuga foetida, d'actéine et de désoxy-actéine
CN110279752B (zh) 速生桉叶提取物及其制备方法和抗hiv应用
JP3010258B2 (ja) 抗ｈｉｖ剤
WO1999051249A1 (fr) Composition a base d'herbes aux fins de la prophylaxie et du traitement du sida
JP2000508654A (ja) Ｄｈｅａ組合せ療法
CN1105238A (zh) 抗aids病毒的药物组合物

Legal Events

Date Code Title Description
FZDE Dead